Abstract
1 The effect of a beta-adrenoceptor blocker without intrinsic sympathomimetic activity (propranolol) and a beta-adrenoceptor blocker with ISA (pindolol) on circadian heart rate was studied in 10 patients (3 women and 7 men) with an average age of 55 years and the following diagnoses: coronary heart disease (n = 7) and hypertension (n = 3). The therapy was carried out in a randomized, cross-over study, with 3 x 40 mg propranolol and 3 x 5 mg pindolol. 2 Propranolol lowered the averaged circadian heart rate significantly (P less than 0.001) from 78 to 68 beats/min. The rate decreased both during the day and at night and the reduction was greater the higher the control value. The minimal hourly heart rate also decreased significantly (P less than 0.005) from 65 to 69 beats/min. 3 After pindolol the averaged circadian heart rate was not markedly changed. It reached a stable rate of around 70 beats/min. At a heart rate of below 70 beats/min an increase in rate was observed, whereas above 70 beats/min a reduction was found. The mean heart rate during the day remained unchanged. There was a significant relationship between the level of the control heart rate and the decrease in rate (r = 0.85, P less than 0.005). 4 In a bicycle exercise test of 1 Watt/kg body weight over a period of 6 min, both beta-adrenoceptor blockers lowered blood pressure and heart rate to the same extent.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aellig W. H. Investigations with beta-adrenoceptor blocking drugs in healthy volunteers. Acta Med Scand Suppl. 1977;606:71–75. doi: 10.1111/j.0954-6820.1977.tb18032.x. [DOI] [PubMed] [Google Scholar]
- Baust W., Bohnert B. The regulation of heart rate during sleep. Exp Brain Res. 1969;7(2):169–180. doi: 10.1007/BF00235442. [DOI] [PubMed] [Google Scholar]
- Beumer H. M., Teirlinck C., Wiseman R. A. Comparative investigation of the respiratory and cardiovascular effect of mepindolol, propranolol and pindolol in asthmatic patients. Int J Clin Pharmacol Biopharm. 1978 Jun;16(6):249–253. [PubMed] [Google Scholar]
- Burch G. E. Of senile cardiomyopathy. Am Heart J. 1979 Jul;98(1):135–135. doi: 10.1016/0002-8703(79)90331-4. [DOI] [PubMed] [Google Scholar]
- Louis W. J., Rand M. J., McNeil J. J., Drummer O., Jarrott B. Clinical pharmacology of adrenergic-blocking drugs. Cardiology. 1979;64 (Suppl 1):96–104. doi: 10.1159/000170654. [DOI] [PubMed] [Google Scholar]
- Lown B., Tykocinski M., Garfein A., Brooks P. Sleep and ventricular premature beats. Circulation. 1973 Oct;48(4):691–701. doi: 10.1161/01.cir.48.4.691. [DOI] [PubMed] [Google Scholar]
- McNeil J. J., Louis W. J. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension. Br J Clin Pharmacol. 1979;8(Suppl 2):163S–166S. [PMC free article] [PubMed] [Google Scholar]
- McNeil J. J., Louis W. J., Doyle A. E., Vajda F. J. Comparison of metoprolol and pindolol in the treatment of mild to moderate hypertension: a double-blind crossover study. Med J Aust. 1979 May 19;1(10):431-2, 461. doi: 10.5694/j.1326-5377.1979.tb127016.x. [DOI] [PubMed] [Google Scholar]
- Oh V. M., Kaye C. M., Warrington S. J., Taylor E. A., Wadsworth J. Studies of cardioselectivity and partial agonist activity in beta-adrenoceptor blockade comparing effects on heart rate and peak expiratory flow rate during exercise. Br J Clin Pharmacol. 1978 Feb;5(2):107–120. doi: 10.1111/j.1365-2125.1978.tb01609.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Svendsen T. L., Hartling O., Trap-Jensen J. Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers. Eur J Clin Pharmacol. 1979 May 21;15(4):223–228. doi: 10.1007/BF00618509. [DOI] [PubMed] [Google Scholar]
